Six-Month Standing Order for Quidel Ortho Diagnostic Reagents
This opportunity is closed
The response deadline has passed. Review the details for future reference or to track similar opportunities.
The National Institutes of Health (NIH) is issuing a six-month standing order for QuidelOrtho reagents, specifically for use with the Vision analyzer. The order is sole-sourced to QuidelOrtho Sales Company, LLC.
Scope & Requirements
Six-month standing order for QuidelOrtho reagents, including various gel cards, Surgiscreen, Affirmagen, and other related supplies.
Deliverables
- Anti-IgG gel cards (MTS084024)
- MTS A/B/D Mono and Reverse gel cards (MTS080515)
- Anti-IgG C3d gel cards (MTS084014)
- Surgiscreen (6902316)
- Affirmagen (719201)
- Resolve Panel A (6902317)
- MTS Round Diluent 2 (MTS9230)
- Alba Q-Chek controls (Z498)
- MTS Round Diluent 2+ (MTS9330)
- BSA 7% (6844285)
- MTS Buffered Gel card (MTS085014)
Attachments
This listing does not include downloadable attachments. The solicitation details may be in the description below.
Verify on SAM.govContract Details
- Contract Type
- firm-fixed-price purchase order
- Estimated Value
- est. $103K – $3.2MSimilar contracts award $11K – $105K (median $31K, 6,018 awards)Above typical range
- Period of Performance
- April 1, 2026 – September 30, 2026
- Incumbent Contractor
- QuidelOrtho Sales Company, LLC
- Expected Awards
- 1
- NAICS Codes
- Place of Performance
- Bethesda, MD, USA
Agency & Contact
Contracting Organization
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-Agency
- Department of Transfusion Medicine
- Office
- National Institutes of Health
Point of Contact
Key Dates
Description
This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health on behalf of the Department of Transfusion Medicine intends to award a firm-fixed-price purchase order on a sole source basis to: QuidelOrtho Sales Company, LLC 9975 Summers Ridge Road San Diego, CA 92121-2997 Decription of Requirement Six (6) month standing order for QuidelOrtho reagents.
Period of Performance: April 1, 2026 – September 30, 2026 Supplies Anti-IgG gel cards (MTS084024) MTS A/B/D Mono and Reverse gel cards (MTS080515) Anti-IgG C3d gel cards (MTS084014) Surgiscreen (6902316) Affirmagen (719201) Resolve Panel A (6902317) MTS Round Diluent 2 (MTS9230) Alba Q-Chek controls (Z498) MTS Round Diluent 2+ (MTS9330) BSA 7% (6844285) MTS Buffered Gel card (MTS085014) Justification QuidelOrtho reagents are the only reagents compatible with the existing Vision analyzer currently used in the department. No authorized distributors exist. Alternate products would require validation and delay patient care. Authority This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT),
contracting officers may solicit from one source if the
contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the
requirements of FAR Part 6-Competition
Requirements. Submission Email capability statements only to: [email protected] Deadline: March 25, 2026 at 09:30 AM EST Shasheshe Goolsby Contracting ., SUITE 503L (No Street Address
Get matched to contracts like this daily
Free AI-powered contract matching for your business.